Signaling Pathway
Important Notice: For research use only. We do not sell to patients.
| Discription | FR 180204 is a novel and selective inhibitor of extracellular signal-regulated kinase (ERK), which may be a potential new therapy for rheumatoid arthritis. | ||
|---|---|---|---|
| Targets |
|
| Catalog Num | A14119 |
|---|---|
| Formula | C18H13N7 |
| Molecular Weight | 327.34 |
| CAS Number | 865362-74-9 |
| SMILES | C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N |
| Synonyms | FR-180204,FR180204 |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 57 mg/mL (174.13 mM) | |
| Water | Insoluble | ||
| Ethanol | Warmed: 2 mg/mL (6.1 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 30.55 mL | 152.75 mL | 305.49 mL |
| 0.5 mM | 6.11 mL | 30.55 mL | 61.1 mL |
| 1 mM | 3.05 mL | 15.27 mL | 30.55 mL |
| 5 mM | 0.61 mL | 3.05 mL | 6.11 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
